Page 1 | Search Results | Diabetes | American Diabetes Association

1-20 of 25

Sort by

Sort Order Select

Journal Articles

Association of Serum Very-Long-Chain Saturated Fatty Acids With Changes in Insulin Sensitivity and β-Cell Function: The Prospective Metabolism and Islet Cell Evaluation (PROMISE) Cohort

Kira Zhi Hua Lai, Zhila Semnani-Azad, Beatrice A. Boucher, Ravi Retnakaran, Stewart B. Harris, Vasanti Malik, Richard P. Bazinet, Anthony J. Hanley

Diabetes 2023;72(11):1664–1670

https://doi.org/10.2337/db22-1050

Published: 16 August 2023

View article titled, Association of Serum Very-Long-Chain Saturated Fatty Acids With Changes in Insulin Sensitivity and β-Cell Function: The Prospective Metabolism and Islet Cell Evaluation (PROMISE) Cohort

Meeting Abstracts

387-P: High Incidences of Level 3 Severe Hypoglycemia Reported by T2DM Secretagogue-Users (iNPHORM, USA)

ALEXANDRIA RATZKI-LEEWING, JASON E. BLACK, GUANGYONG ZOU, BRIDGET L. RYAN, STEWART B. HARRIS

Diabetes 2023;72(Supplement_1):387-P

https://doi.org/10.2337/db23-387-P

Published: 20 June 2023

View article titled, 387-P: High Incidences of Level 3 Severe Hypoglycemia Reported by T2DM Secretagogue-Users (iNPHORM, USA)

Meeting Abstracts

3-OR: Severe Hypoglycemia among Older Adults with Diabetes (iNPHORM, USA)

ALEXANDRIA RATZKI-LEEWING, JASON E. BLACK, GUANGYONG ZOU, BRIDGET L. RYAN, STEWART B. HARRIS

Diabetes 2023;72(Supplement_1):3-OR

https://doi.org/10.2337/db23-3-OR

Published: 20 June 2023

View article titled, 3-OR: Severe Hypoglycemia among Older Adults with Diabetes (iNPHORM, USA)

Meeting Abstracts

379-P: Patient and Physician Experience of Hypoglycemia during Basal Insulin (BI) Titration in Type 2 Diabetes (T2D) in the U.S.

STEWART B. HARRIS, KAMEL MOHAMMEDI, MONICA BERTOLINI, VALERY WALKER, MAUREEN H. CARLYLE, FANG L. ZHOU, JOCHEN SEUFERT, JOHN E. ANDERSON

Diabetes 2022;71(Supplement_1):379-P

https://doi.org/10.2337/db22-379-P

Published: 01 June 2022

View article titled, 379-P: Patient and Physician Experience of Hypoglycemia during Basal Insulin (BI) Titration in Type 2 Diabetes (T2D) in the U.S.

Meeting Abstracts

372-P: Predicting Real-World Severe Hypoglycemia in Americans with Diabetes (iNPHORM)

ALEXANDRIA RATZKI-LEEWING, STEWART B. HARRIS, JASON E. BLACK, GUANGYONG ZOU, SUSAN WEBSTER-BOGAERT, BRIDGET L. RYAN

Diabetes 2022;71(Supplement_1):372-P

https://doi.org/10.2337/db22-372-P

Published: 01 June 2022

View article titled, 372-P: Predicting Real-World Severe Hypoglycemia in Americans with Diabetes (iNPHORM)

Meeting Abstracts

371-P: Predicting Real-World Nonsevere Hypoglycemia in Americans with Diabetes (iNPHORM)

ALEXANDRIA RATZKI-LEEWING, STEWART B. HARRIS, JASON E. BLACK, GUANGYONG ZOU, SUSAN WEBSTER-BOGAERT, BRIDGET L. RYAN

Diabetes 2022;71(Supplement_1):371-P

https://doi.org/10.2337/db22-371-P

Published: 01 June 2022

View article titled, 371-P: Predicting Real-World Nonsevere Hypoglycemia in Americans with Diabetes (iNPHORM)

Meeting Abstracts

512-P: Physician Perspectives and Experiences with Basal Insulin Titration in Type 2 Diabetes: A U.S. Cross-Sectional Survey

STEWART B. HARRIS, JOCHEN SEUFERT, MONICA BERTOLINI, VALERY WALKER, JOHN C. WHITE, FANG L. ZHOU, KAMEL MOHAMMEDI, JOHN E. ANDERSON

Diabetes 2022;71(Supplement_1):512-P

https://doi.org/10.2337/db22-512-P

Published: 01 June 2022

View article titled, 512-P: Physician Perspectives and Experiences with Basal Insulin Titration in Type 2 Diabetes: A U.S. Cross-Sectional Survey

Meeting Abstracts

680-P: Effect of the FreeStyle Libre System on Diabetes Treatment for People with T2D: Results from a Retrospective Cohort Study Using Canadian Private Payer Claims Database

STEWART B. HARRIS, FLEUR LEVRAT-GUILLEN

Diabetes 2022;71(Supplement_1):680-P

https://doi.org/10.2337/db22-680-P

Published: 01 June 2022

View article titled, 680-P: Effect of the FreeStyle Libre System on Diabetes Treatment for People with T2D: Results from a Retrospective Cohort Study Using Canadian Private Payer Claims Database

Meeting Abstracts

1241-P: Cross-Sectional Study of the Impact of the COVID-Pandemic on Diabetes Management in Primary Care in Ontario, Canada

ALICE Y. CHENG, STEWART B. HARRIS, IRIS E. KRAWCHENKO, RICHARD TYTUS, JINA HAHN, AIDEN R. LIU, YANG WANG, SHANE GOLDEN, RONALD GOLDENBERG

Diabetes 2022;71(Supplement_1):1241-P

https://doi.org/10.2337/db22-1241-P

Published: 01 June 2022

View article titled, 1241-P: Cross-Sectional Study of the Impact of the COVID-Pandemic on Diabetes Management in Primary Care in Ontario, Canada

Meeting Abstracts

813-P: Treatment Satisfaction and Health Status in People with T2D Treated with Insulin Glargine 300 U/mL (Gla-300) : Patient-Reported Outcomes (PRO) from ATOS Study

NIAZ KHAN, AMIR TIROSH, ANIL BHANSALI, HERNANDO VARGAS-URICOECHEA, STEWART B. HARRIS, AUDE ROBOREL DE CLIMENS, MARIA AILEEN N. MABUNAY, MATHIEU COUDERT, VALERIE PILORGET, GAGIK R. GALSTYAN

Diabetes 2022;71(Supplement_1):813-P

https://doi.org/10.2337/db22-813-P

Published: 01 June 2022

View article titled, 813-P: Treatment Satisfaction and Health Status in People with T2D Treated with Insulin Glargine 300 U/mL (Gla-300) : Patient-Reported Outcomes (PRO) from ATOS Study

Meeting Abstracts

268-OR: Impact of the COVID-Pandemic on Antihyperglycemic Prescription Patterns in Canada

ALICE Y. CHENG, RONALD GOLDENBERG, IRIS E. KRAWCHENKO, RICHARD TYTUS, JINA HAHN, AIDEN R. LIU, TOMMY LAN, BRADLEY MILLSON, STEWART B. HARRIS

Diabetes 2022;71(Supplement_1):268-OR

https://doi.org/10.2337/db22-268-OR

Published: 01 June 2022

View article titled, 268-OR: Impact of the COVID-Pandemic on Antihyperglycemic Prescription Patterns in Canada

Meeting Abstracts

721-P: Insulin-Sparing Effects of Oral Semaglutide: An Analysis of PIONEER 8

VANITA R. ARODA, MORTEN T. ABILDLUND, RIKKE AGESEN, STEWART B. HARRIS, BANAFSHEH ZAHEDI, BERNARD ZINMAN, EIICHI ARAKI

Diabetes 2022;71(Supplement_1):721-P

https://doi.org/10.2337/db22-721-P

Published: 01 June 2022

View article titled, 721-P: Insulin-Sparing Effects of Oral Semaglutide: An Analysis of PIONEER 8

Meeting Abstracts

677-P: Remission of Type 2 Diabetes following Intensive Treatment with Insulin Glargine, Lixisenatide, Metformin, and Lifestyle Approaches: Results of a Multicenter Randomized Controlled Trial

NATALIA MCINNES, STEPHANIE HALL, HEATHER A. LOCHNAN, STEWART B. HARRIS, ZUBIN PUNTHAKEE, RONALD J. SIGAL, IRENE HRAMIAK, MOHAMMED AZHARUDDIN, JOANNE F. LIUTKUS, JEAN-FRANÇOIS YALE, FARAH SULTAN, ADA C. SMITH, ROSE E. OTTO, DIANA SHERIFALI, YAN YUN LIU, HERTZEL C. GERSTEIN, REMIT-IGLARLIXI COLLABORATIVE GROUP

Diabetes 2021;70(Supplement_1):677-P

https://doi.org/10.2337/db21-677-P

Published: 01 June 2021

View article titled, 677-P: Remission of Type 2 Diabetes following Intensive Treatment with Insulin Glargine, Lixisenatide, Metformin, and Lifestyle Approaches: Results of a Multicenter Randomized Controlled Trial

Meeting Abstracts

347-P: Why Some Americans Use Health Care following Severe Hypoglycemia, and Why Some Do Not: Baseline Results of the iNPHORM Study

ALEXANDRIA RATZKI-LEEWING, JASON E. BLACK, BRIDGET L. RYAN, GUANGYONG ZOU, STEWART B. HARRIS

Diabetes 2021;70(Supplement_1):347-P

https://doi.org/10.2337/db21-347-P

Published: 01 June 2021

View article titled, 347-P: Why Some Americans Use Health Care following Severe Hypoglycemia, and Why Some Do Not: Baseline Results of the iNPHORM Study

Meeting Abstracts

95-LB: LixilanONE CAN: Randomized Trial Comparing a Daily vs. Weekly Titration Algorithm for Switching from Basal Insulin to iGlarLixi Fixed-Ratio Combination in People with T2DM in Canada

IRENE HRAMIAK, HERTZEL C. GERSTEIN, LAWRENCE A. LEITER, JEAN-FRANÇOIS YALE, HARPREET S. BAJAJ, JOHN A. STEWART, MARIE-JOSEE TOUTOUNJI, STEWART B. HARRIS

Diabetes 2021;70(Supplement_1):95-LB

https://doi.org/10.2337/db21-95-LB

Published: 01 June 2021

View article titled, 95-LB: LixilanONE CAN: Randomized Trial Comparing a Daily vs. Weekly Titration Algorithm for Switching from Basal Insulin to iGlarLixi Fixed-Ratio Combination in People with T2DM in Canada

Meeting Abstracts

385-P: Health-Care Providers’ Emotional Responses to Their Patients’ Hypoglycemic Events: The InHypo-DM Study

SONJA M. REICHERT, JUDITH B. BROWN, YASHODA VALLIERE, CECELIA MCLACHLAN, SUSAN WEBSTER-BOGAERT, ALEXANDRIA RATZKI-LEEWING, BRIDGET L. RYAN, NATALIE H. AU, STEWART B. HARRIS

Diabetes 2020;69(Supplement_1):385-P

https://doi.org/10.2337/db20-385-P

Published: 01 June 2020

View article titled, 385-P: Health-Care Providers’ Emotional Responses to Their Patients’ Hypoglycemic Events: The InHypo-DM Study

Meeting Abstracts

956-P: Efficacy and Safety of Oral Semaglutide When Added to Basal, Premix, or Basal-Bolus Insulin

OFRI MOSENZON, VANITA R. ARODA, ERIK CHRISTIANSEN, STEWART B. HARRIS, KAREN BOJE PEDERSEN, MADS JEPPE TARP-JOHANSEN, BERNARD ZINMAN

Diabetes 2020;69(Supplement_1):956-P

https://doi.org/10.2337/db20-956-P

Published: 01 June 2020

View article titled, 956-P: Efficacy and Safety of Oral Semaglutide When Added to Basal, Premix, or Basal-Bolus Insulin

Meeting Abstracts

2192-PUB: Treatment Satisfaction in People with Type 2 Diabetes (T2D) Receiving Basal Insulin (BI): Results from Real-World Studies and Randomized Controlled Trials (RCTs) with Insulin Glargine 300 U/mL (Gla-300)

STEWART B. HARRIS, FRANK J. SNOEK, LUIGI MENEGHINI, FELIPE LAUAND, SR., JUKKA WESTERBACKA, AUDE ROBOREL DE CLIMENS, KAMLESH KHUNTI

Diabetes 2020;69(Supplement_1):2192-PUB

https://doi.org/10.2337/db20-2192-PUB

Published: 01 June 2020

View article titled, 2192-PUB: Treatment Satisfaction in People with Type 2 Diabetes (T2D) Receiving Basal Insulin (BI): Results from Real-World Studies and Randomized Controlled Trials (RCTs) with Insulin Glargine 300 U/mL (Gla-300)

Meeting Abstracts

381-P: Real-World Evidence that Impaired Awareness of Hypoglycemia Increases Severe Hypoglycemia Rates in T2DM (InHypo-DM Study)

ALEXANDRIA RATZKI-LEEWING, STEWART B. HARRIS, NATALIE H. AU, SUSAN WEBSTER-BOGAERT, JUDITH B. BROWN, SONJA M. REICHERT, BRIDGET L. RYAN

Diabetes 2019;68(Supplement_1):381-P

https://doi.org/10.2337/db19-381-P

Published: 01 June 2019

View article titled, 381-P: Real-World Evidence that Impaired Awareness of Hypoglycemia Increases Severe Hypoglycemia Rates in T2DM (InHypo-DM Study)

Meeting Abstracts

1095-P: Early Hypoglycemia after Initiation of Second-Generation Basal Insulin (BI) Analogs: Patient Characteristics and Clinical Outcomes

STEWART B. HARRIS, LORI BERARD, JUKKA WESTERBACKA, ZSOLT BOSNYAK, LYDIE MELAS-MELT, FELIPE LAUAND, SR., TIMOTHY S. BAILEY, KAMLESH KHUNTI

Diabetes 2019;68(Supplement_1):1095-P

https://doi.org/10.2337/db19-1095-P

Published: 01 June 2019

View article titled, 1095-P: Early Hypoglycemia after Initiation of Second-Generation Basal Insulin (BI) Analogs: Patient Characteristics and Clinical Outcomes

NARROW

Association of Serum Very-Long-Chain Saturated Fatty Acids With Changes in Insulin Sensitivity and β-Cell Function: The Prospective Metabolism and Islet Cell Evaluation (PROMISE) Cohort

387-P: High Incidences of Level 3 Severe Hypoglycemia Reported by T2DM Secretagogue-Users (iNPHORM, USA)

3-OR: Severe Hypoglycemia among Older Adults with Diabetes (iNPHORM, USA)

379-P: Patient and Physician Experience of Hypoglycemia during Basal Insulin (BI) Titration in Type 2 Diabetes (T2D) in the U.S.

372-P: Predicting Real-World Severe Hypoglycemia in Americans with Diabetes (iNPHORM)

371-P: Predicting Real-World Nonsevere Hypoglycemia in Americans with Diabetes (iNPHORM)

512-P: Physician Perspectives and Experiences with Basal Insulin Titration in Type 2 Diabetes: A U.S. Cross-Sectional Survey

680-P: Effect of the FreeStyle Libre System on Diabetes Treatment for People with T2D: Results from a Retrospective Cohort Study Using Canadian Private Payer Claims Database

1241-P: Cross-Sectional Study of the Impact of the COVID-Pandemic on Diabetes Management in Primary Care in Ontario, Canada

813-P: Treatment Satisfaction and Health Status in People with T2D Treated with Insulin Glargine 300 U/mL (Gla-300) : Patient-Reported Outcomes (PRO) from ATOS Study

268-OR: Impact of the COVID-Pandemic on Antihyperglycemic Prescription Patterns in Canada

721-P: Insulin-Sparing Effects of Oral Semaglutide: An Analysis of PIONEER 8

677-P: Remission of Type 2 Diabetes following Intensive Treatment with Insulin Glargine, Lixisenatide, Metformin, and Lifestyle Approaches: Results of a Multicenter Randomized Controlled Trial

347-P: Why Some Americans Use Health Care following Severe Hypoglycemia, and Why Some Do Not: Baseline Results of the iNPHORM Study

95-LB: LixilanONE CAN: Randomized Trial Comparing a Daily vs. Weekly Titration Algorithm for Switching from Basal Insulin to iGlarLixi Fixed-Ratio Combination in People with T2DM in Canada

385-P: Health-Care Providers’ Emotional Responses to Their Patients’ Hypoglycemic Events: The InHypo-DM Study

956-P: Efficacy and Safety of Oral Semaglutide When Added to Basal, Premix, or Basal-Bolus Insulin

2192-PUB: Treatment Satisfaction in People with Type 2 Diabetes (T2D) Receiving Basal Insulin (BI): Results from Real-World Studies and Randomized Controlled Trials (RCTs) with Insulin Glargine 300 U/mL (Gla-300)

381-P: Real-World Evidence that Impaired Awareness of Hypoglycemia Increases Severe Hypoglycemia Rates in T2DM (InHypo-DM Study)

1095-P: Early Hypoglycemia after Initiation of Second-Generation Basal Insulin (BI) Analogs: Patient Characteristics and Clinical Outcomes

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

This Feature Is Available To Subscribers Only